Archive - Cardiology Trial’s Substack

Summary and discussion of Carvedilol Prospective Randomized Cumulative Survival Study, Val-HeFT, CHARM-Added and CIBIS-II

Jun 19 •

Cardiology Trials

57:14

Review of the CIBIS-II Trial

Bisoprolol in systolic heart failure

Jun 17 •

Cardiology Trials

Review of the CHARM-Added trial

Candesartan in systolic Heart Failure

Jun 11 •

Cardiology Trials

Review of the Val-HeFT trial

Valsartan in Chronic Heart Failure

Jun 6 •

Cardiology Trials

Review of the Carvedilol Prospective Randomized Cumulative Survival Study

Effect of carvedilol on survival in severe chronic heart failure

Jun 4 •

Cardiology Trials

May 2025

Summary and discussion of U.S. Carvedilol Heart Failure, DIG, RALES, MERIT-HF, and ATLAS

May 30 •

Cardiology Trials

1:09:37

Review of the ATLAS trial

Low vs high dose of ACEi in systolic heart failure

May 27 •

Cardiology Trials

Review of the MERIT-HF trial

Effect of metoprolol CR/XL in chronic heart failure

May 22 •

Cardiology Trials

Review of the RALES trial

Spironolactone in Patients with Severe Heart Failure

May 20 •

Cardiology Trials

Review of the DIG trial

The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure

May 16 •

Cardiology Trials

Review of the U.S. Carvedilol Heart Failure Study

Carvedilol vs placebo in patients with systolic heart failure

May 14 •

Cardiology Trials

Summary and discussion of V-HEFT II and SOLVD

May 9 •

Cardiology Trials

37:22

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts